blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability
Register Forum

2022.02.11

More...
blank News flashes

News flashes

New version of the European Patent Register - SPC information for Unitary Patents.

2024-03-06

More...
blank Related links

Extract from the Register of European Patents

EP About this file: EP2032568

EP2032568 - POLYCYCLIC HETEROCYCLIC COMPOUNDS AND THEIR USE AS MODULATORS OF THE METABOTROPIC GLUTAMATE 5 RECEPTOR [Right-click to bookmark this link]
StatusThe application is deemed to be withdrawn
Status updated on  15.01.2010
Database last updated on 13.07.2024
Most recent event   Tooltip15.01.2010Application deemed to be withdrawnpublished on 17.02.2010  [2010/07]
Applicant(s)For all designated states
AstraZeneca AB
151 85 Södertälje / SE
[2009/11]
Inventor(s)01 / ISAAC, Methvin
17 Reynolds Ave.
Brampton, Ontario L6P 2C1 / CA
02 / SLASSI, Abdelmalik
4780 Fulwell Road
Mississauga, Ontario L5M 7J7 / CA
03 / EDWARDS, Louise
871 Chippenham Dr.
Mississauga, Ontario L5H 3S6 / CA
04 / XIN, Tao
10 Comoq Ave.
Woodbridge, Ontario L4H 2B1 / CA
05 / WALLBERG, Andreas
AstraZeneca R & D
431 83 Mölndal / SE
06 / STEFANAC, Tomislav
4483 Bennett Rd.
Burlington, Ontario L7L 1Y5 / CA
 [2009/11]
Application number, filing date07811854.425.04.2007
[2009/11]
WO2007US67370
Priority number, dateUS20060797662P05.05.2006         Original published format: US 797662 P
[2009/11]
Filing languageEN
Procedural languageEN
PublicationType: A2 Application without search report
No.:WO2007130823
Date:15.11.2007
Language:EN
[2007/46]
Type: A2 Application without search report 
No.:EP2032568
Date:11.03.2009
Language:EN
The application published by WIPO in one of the EPO official languages on 15.11.2007 takes the place of the publication of the European patent application.
[2009/11]
Search report(s)International search report - published on:EP24.01.2008
ClassificationIPC:C07D413/14, A61K31/4439, A61P25/02, A61P25/22, A61P1/00
[2009/11]
CPC:
C07D207/16 (EP,US); A61P1/00 (EP); A61P1/04 (EP);
A61P1/06 (EP); A61P1/12 (EP); A61P25/02 (EP);
A61P25/04 (EP); A61P25/06 (EP); A61P25/22 (EP);
A61P29/00 (EP); C07D207/08 (EP,US); C07D207/09 (EP,US);
C07D213/78 (EP,US); C07D213/79 (EP,US); C07D413/04 (EP,US);
C07D413/14 (EP,US) (-)
Designated contracting statesAT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MT,   NL,   PL,   PT,   RO,   SE,   SI,   SK,   TR [2009/11]
Extension statesALNot yet paid
BANot yet paid
HRNot yet paid
MKNot yet paid
RSNot yet paid
TitleGerman:POLYCYCLISCHE UND HETEROCYCLISCHE VERBINDUNGEN UND IHRE VERWENDUNG ALS MODULATOREN DES METABOTROPEN GLUTAMAT-5-REZEPTORS[2009/11]
English:POLYCYCLIC HETEROCYCLIC COMPOUNDS AND THEIR USE AS MODULATORS OF THE METABOTROPIC GLUTAMATE 5 RECEPTOR[2009/11]
French:COMPOSES POLYCYCLIQUES ET HETEOCYCLIQUES ET LEUR UTILISATION EN TANT QUE MODULATEURS DES RÉCEPTEURS METABOLIQUES GLUTAMATE 5[2009/11]
Entry into regional phase05.12.2008National basic fee paid 
05.12.2008Designation fee(s) paid 
05.12.2008Examination fee paid 
Examination procedure25.11.2008Amendment by applicant (claims and/or description)
05.12.2008Examination requested  [2009/11]
16.04.2009Despatch of a communication from the examining division (Time limit: M04)
27.08.2009Application deemed to be withdrawn, date of legal effect  [2010/07]
02.10.2009Despatch of communication that the application is deemed to be withdrawn, reason: reply to the communication from the examining division not received in time  [2010/07]
Fees paidPenalty fee
Additional fee for renewal fee
30.04.200903   M06   Not yet paid
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Cited inInternational search[X]WO2005080386  (ASTRAZENECA AB [SE], et al) [X] 1-24 * claim 1 *;
 [A]WO2005080379  (ASTRAZENECA AB [SE], et al) [A] 1-24 * The whole document *;
 [A]WO2005044797  (ADDEX PHARMACEUTICALS SA [CH], et al) [A] 1-24 * The whole document *;
 [A]  - DAVID GARVEY ET AL, "Ligands for Brain Cholinergic Channel Receptors: Synthesis and in Vitro Characterization of Novel Isoxazoles and Isothiazoles as Bioisosteric Replacements for the Pyridine Ring in Nicotine", JOURNAL OF MEDICINAL CHEMISTRY, (1994), vol. 37, pages 4455 - 4463, XP002455070 [A] 24 * page 4456, scheme 2 *

DOI:   http://dx.doi.org/10.1021/jm00052a005
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.